Sree Rayalaseema Alkalies & Allied Chemicals is currently trading at Rs. 26.70, up by 0.70 points or 2.69% from its previous closing of Rs. 26.00 on the BSE.
The scrip opened at Rs. 27.50 and has touched a high and low of Rs. 27.60 and Rs. 26.30 respectively. So far 519254 shares were traded on the counter.
The BSE group 'XC' stock of face value Rs. 10 has touched a 52 week high of Rs. 29.10 on 26-Oct-2016 and a 52 week low of Rs. 17.00 on 22-Nov-2016.
Last one week high and low of the scrip stood at Rs. 28.30 and Rs. 25.35 respectively. The current market cap of the company is Rs. 232.02 crore.
The promoters holding in the company stood at 54.79%, while institutions and non-institutions held 0.73% and 44.48% respectively.
Sree Rayalaseema Alkalies & Allied Chemicals has posted over 2-fold jump in its net profit at Rs 5.94 crore for the quarter ended March 31, 2017 as compared to Rs 2.23 crore for the same quarter in the previous year. Total income from operations of the company increased marginally by 2.57% at Rs 232.38 crore for quarter under review as compared to Rs 226.55 crore for the quarter ended March 31, 2016.
For the year ended March 31, 2017, the company has posted a fall of 20.39% in its net profit at Rs 19.44 crore as compared to Rs 24.42 crore in FY16. However, total income from operations of company increased by 11.09% at Rs 906.92 crore for year under review as compared to Rs 816.39 crore for the year ended March 31, 2016.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: